Asthma costs and social impact.
Asthma costs and social impact.
复制标题
DOI：
10.1186/s40733-016-0029-3
复制
发表时间：
2017
影响因子：
--
通讯作者：
Morais-Almeida M
中科院分区：
文献类型：
--
作者：
Nunes C;Pereira AM;Morais-Almeida M
近几十年来，哮喘的患病率和发病率在全球范围内都在增加，这不仅是由于遗传背景，而且主要是由于许多环境和生活方式危险因素的影响。在许多国家，哮喘等非传染性疾病尚未被视为医疗保健的优先事项。本综述将分析和讨论几个国家和地区在哮喘管理方面的差异，例如获得医疗保健人力资源和药物，因为财政能力有限，无法制定控制和预防这种慢性疾病的策略。本文就哮喘的社会经济负担对社会的影响进行综述。虽然哮喘被普遍认为是一种昂贵的疾病，但社会的总成本（直接，间接和无形的哮喘成本）很难估计，主要是由于不同的疾病定义和特征，以及不同社会使用不同的方法来评估哮喘的社会经济影响。哮喘费用在不同国家之间存在很大差异，但我们可以估计，欧洲每位患者每年的平均费用，包括所有哮喘患者（间歇性，轻度，中度和重度哮喘）为1，900美元，似乎低于美国，估计平均为3，100美元。
In recent decades, both asthma prevalence and incidence have been increasing worldwide, not only due to the genetic background, but mainly because of the effect of a wide number of environmental and lifestyle risk factors. In many countries noncommunicable diseases, like asthma, are not yet considered a healthcare priority. This review will analyze and discuss disparities in asthma management in several countries and regions, such as access to healthcare human resources and medications, due to limited financial capacity to develop strategies to control and prevent this chronic disease. This review tries to explore the social and economic burden of asthma impact on society. Although asthma is generally accepted as a costly illness, the total costs to society (direct, indirect and intangible asthma costs) are difficult to estimate, mainly due to different disease definitions and characterizations but also to the use of different methodologies to assess the asthma socio-economic impact in different societies. The asthma costs are very variables from country to country, however we can estimate that a mean cost per patient per year, including all asthmatics (intermittent, mild, moderate and severe asthma) in Europe is $USD 1,900, which seems lower than USA, estimated mean $USD 3,100.